ArticleHuman gene therapy. Clinical development2015

A GLP-Compliant Toxicology and Biodistribution Study: Systemic Delivery of an rAAV9 Vector for the Treatment of Mucopolysaccharidosis IIIB.

Aaron S Meadows et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.